Podcast

From Cancer to Capitol Hill

Author(s):

In this week’s episode of CURE Talks Cancer, we speak with Rose Gerber, director of patient advocacy at CPAN, about her experience with breast cancer, how she became an advocate and how her journey helped her to see beyond the cancer experience.

As a young mother, Rose Gerber faced a HER2-positive breast cancer diagnosis at an early stage in life — and during a time where this disease had poorer outcomes. Despite this feat, Rose used her personal experience, in combination with her professional skillset, to help other patients with cancer through the Community Oncology Alliance Patient Advocacy Network (CPAN).

Since, Rose — who is the director of patient advocacy at CPAN – has met with legislators on Capitol Hill to discuss cancer policy issues and has also assisted in developing programs across the country.

In this week’s episode of CURE Talks Cancer, we speak with Rose about her experience with breast cancer, how she became an advocate and how her journey helped her to see beyond the cancer experience.

To learn more, visit the CPAN site on curetoday.com.

In this week’s episode of CURE Talks Cancer, we speak with Rose Gerber, director of patient advocacy at CPAN, about her experience with breast cancer, how she became an advocate and how her journey helped her to see beyond the cancer experience.

Related Videos
Image of woman with blonde hair.
Image of woman with brown hair.
a man and a woman in front of a dark blue background
a man and a woman in front of a dark blue background
a man and a woman in separate boxes in front of a dark blue background
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine in the Department of Medicine at Beth Israel Deaconess Medical Center in Boston.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Related Content